-
Founded in:
1999-04-28 -
Country:
China -
Address:
No. 3888, Xuyou East Road, Dongcheng District, Xuchang City -
Tax NO.:
9141100071128293X8 -
Registered Funds:
255 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ciclopirox ethanolamine |
Ciclopirox is a broad-spectrum antifungal drug that has antifungal effects on pathogenic fungi that can cause nail fungus infections.
More
Ciclopirox is a broad-spectrum antifungal drug that has antifungal effects on pathogenic fungi that can cause nail fungus infections. |
10mg | 41621-49-2 | 12 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Chlordiazepoxide |
Poisoning symptoms: When poisoned by a large dose, coma, hypotension, respiratory depression and bradycardia may occur. Treatment: Immediately induce vomiting, gastric lavage and catharsis to eliminate the drug, and give symptomatic treatment and supportive therapy according to the condition.
More
Poisoning symptoms: When poisoned by a large dose, coma, hypotension, respiratory depression and bradycardia may occur. Treatment: Immediately induce vomiting, gastric lavage and catharsis to eliminate the drug, and give symptomatic treatment and supportive therapy according to the condition. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Indometacin |
This product has anti-inflammatory, antipyretic and analgesic effects. Its mechanism of action is to reduce the synthesis of prostaglandins by inhibiting cyclooxygenase. It stops the formation of pain nerve impulses in inflammatory tissues and inhibits inflammatory reactions, including inhibiting the chemotaxis of leukocytes and the release of lysosomal enzymes. As for the antipyretic effect, it acts on the hypothalamic temperature regulation center, causing peripheral vasodilation and sweating, which increases heat dissipation. This central antipyretic effect may also be related to the inhibition of prostaglandin synthesis in the hypothalamus.
More
This product has anti-inflammatory, antipyretic and analgesic effects. Its mechanism of action is to reduce the synthesis of prostaglandins by inhibiting cyclooxygenase. It stops the formation of pain nerve impulses in inflammatory tissues and inhibits inflammatory reactions, including inhibiting the chemotaxis of leukocytes and the release of lysosomal enzymes. As for the antipyretic effect, it acts on the hypothalamic temperature regulation center, causing peripheral vasodilation and sweating, which increases heat dissipation. This central antipyretic effect may also be related to the inhibition of prostaglandin synthesis in the hypothalamus. |
53-86-1 | 23 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Proglumide |
This product is a gastrin receptor antagonist, which can significantly inhibit the secretion of gastric acid and pepsin caused by gastrin, but has no significant effect on the gastric acid secretion caused by histamine and vagus nerve stimulation. It can increase the content of hexosamine in the gastric mucosa, promote glycoprotein synthesis, and protect and promote the healing of the gastric mucosa. It has a choleretic effect, and can prevent stone formation and improve bile duct function by stimulating bile acid-independent bile secretion, changing the stone-forming factors in bile, and antagonizing CCK. The use of this product to treat peptic ulcers and gastritis does not cause rebound gastric acid secretion, and gastric acid secretion can remain at a normal level for up to half a year after the treatment is terminated.
More
This product is a gastrin receptor antagonist, which can significantly inhibit the secretion of gastric acid and pepsin caused by gastrin, but has no significant effect on the gastric acid secretion caused by histamine and vagus nerve stimulation. It can increase the content of hexosamine in the gastric mucosa, promote glycoprotein synthesis, and protect and promote the healing of the gastric mucosa. It has a choleretic effect, and can prevent stone formation and improve bile duct function by stimulating bile acid-independent bile secretion, changing the stone-forming factors in bile, and antagonizing CCK. The use of this product to treat peptic ulcers and gastritis does not cause rebound gastric acid secretion, and gastric acid secretion can remain at a normal level for up to half a year after the treatment is terminated. |
6620-60-6 | 7 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| D-Glucurone |
Extract from the above information
More
Extract from the above information |
32449-92-6 | 6 |